Cell-surface entry and uptake machinery

Cell-surface entry and uptake machinery is a broad functional term describing the collective set of proteins and pathways responsible for the internalization of extracellular materials, including nutrients, signaling molecules, and pathogens. This machinery is not a single molecular target but a complex system involving cell-surface receptors (e.g., ACE2, LDLR), adaptor proteins (e.g., AP-2), and mechanical components such as clathrin and dynamin that facilitate the formation and scission of endocytic vesicles (Nature, 2009, 458:1122-1128). In pharmacology, this machinery is a critical focal point for treating viral infections, where drugs like Umifenovir or Amantadine aim to block the entry or uncoating of viruses (PubMed: 18445316). Additionally, components of this system are targeted in metabolic diseases, such as the use of Ezetimibe to inhibit NPC1L1-mediated cholesterol uptake (PubMed: 15132951). Because these pathways are fundamental to normal cellular homeostasis, therapeutic strategies must achieve high specificity for the disease-relevant component to avoid significant safety concerns related to impaired nutrient acquisition and signal transduction (Reactome, R-HSA-8876343).

Other names

Endocytic machineryCellular entry pathwaysInternalization apparatusViral entry machineryEndocytic apparatus

Inhibition of various stages of cellular entry, including ligand-receptor binding, clathrin-mediated endocytosis, dynamin-dependent vesicle scission, or membrane fusion.